Author:
Dosset Magalie,Castro Andrea,Xian Su,Carter Hannah,Zanetti Maurizio
Publisher
Springer International Publishing
Reference194 articles.
1. Ahmed S, Passos JF, Birket MJ, Beckmann T, Brings S, Peters H, Birch-Machin MA, von Zglinicki T, Saretzki G (2008) Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121:1046–1053. https://doi.org/10.1242/jcs.019372
2. Akiyama M, Hideshima T, Hayashi T, Tai Y-T, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC (2003) Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 63:18–21
3. Albertson DG (2006) Gene amplification in cancer. Trends Genet 22:447–455. https://doi.org/10.1016/j.tig.2006.06.007
4. Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt MV, Bürdek M, Berking C, Prinz JC (2019) Clonality of CD4+ blood T cells predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma. Front Immunol 10:1336. https://doi.org/10.3389/fimmu.2019.01336
5. Armanios M, Blackburn EH (2012) The telomere syndromes. Nat Rev Genet 13:693–704. https://doi.org/10.1038/nrg3246